For the media

Corporate headquarters

Boulder, CO

Founded

In 2000 by Larry Gold, Ph. D.

Number of employees

>500

Stock

NASDAQ: SLGC

Leadership

Publications

News releases

Press contact

[email protected]

Measuring what matters

Our SomaScan® Platform provides insight into human biology based on measuring thousands of proteins in a single biological sample. Read more

Why measure proteins?

Proteins are the most accurate measure of current health states and future disease risks. Read more

One sample, multiple insights

Proteomics is powering transformational research that discovers life-changing drugs and brings safer and more effective treatments to patients faster. Read more

The predictive promise of proteomics

Proteomics is revolutionizing the continuum of care from improving the accuracy of prognostic and diagnostic testing to uncovering new treatment options for patients through advances in precision medicine. Read more

Latest press releases

JAN 31 2023

SomaLogic announces Certified Site expansion through world-class multiomics initiative with Group 42 Healthcare

BOULDER, Colo., Jan. 31, 2023 (GLOBE NEWSWIRE) — SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced the expansion of its SomaLogic® Certified Site program through a recently-launched, world-class proteomics initiative with Group 42 Healthcare (G42), an

View now

JAN 9 2023

SomaLogic Announces Preliminary Full Year 2022 Revenue and Provides Organizational and Strategic Updates

Presenting at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023, at 11:15 a.m. Pacific Time BOULDER, Colo., Jan. 09, 2023 (GLOBE NEWSWIRE) — SomaLogic, Inc., a leader in proteomics technology, today announced that preliminary, unaudited revenue for the full year 2022…

View now

DEC 19 2022

FonesLife offers the 7,000-plex SomaScan® Platform as Japan’s first SomaLogic® Certified Site

TOKYO and BOULDER, Colo., Dec. 19, 2022 (GLOBE NEWSWIRE) — SomaLogic, Inc., a leader in proteomic technology, announced today that Tokyo-based FonesLife Corporation, will be the first SomaLogic® Certified Site in Japan. The new site will offer the 7,000-plex SomaScan ® Assay in their labs and…

View now